Skip to main content
. Author manuscript; available in PMC: 2021 Jun 3.
Published in final edited form as: J Gastroenterol Hepatol. 2020 Sep 3;36(4):1110–1117. doi: 10.1111/jgh.15211

Fig. 3. Total numbers of HCV treatments required over 11 years (2019–2030) to achieve the WHO targets for incidence (green bars) and mortality (orange bars) with different treatment prioritization scenarios (all, cirrhotic, PWID, PWID and cirrhotic).

Fig. 3

40% OST: scale up of opioid substitution therapy to 40% coverage among PWID. Star: WHO 2030 target not achieved. Mean number of HCV PWID and/or ex-PWID needed to treat in the first year are indicated above each bar plot, with the proportion of runs reaching the target in parentheses